• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

作者信息

Günther Gunar, Lange Christoph, Alexandru Sofia, Altet Neus, Avsar Korkut, Bang Didi, Barbuta Raisa, Bothamley Graham, Ciobanu Ana, Crudu Valeriu, Danilovits Manfred, Dedicoat Martin, Duarte Raquel, Gualano Gina, Kunst Heinke, de Lange Wiel, Leimane Vaira, Magis-Escurra Cecile, McLaughlin Anne-Marie, Muylle Inge, Polcová Veronika, Popa Christina, Rumetshofer Rudolf, Skrahina Alena, Solodovnikova Varvara, Spinu Victor, Tiberi Simon, Viiklepp Piret, van Leth Frank

机构信息

Research Center Borstel, Borstel, Germany

Institute of Phtisiopneumology, Chisinau, Moldova.

出版信息

N Engl J Med. 2016 Sep 15;375(11):1103-5. doi: 10.1056/NEJMc1603274.

DOI:10.1056/NEJMc1603274
PMID:27626539
Abstract
摘要

相似文献

1
Treatment Outcomes in Multidrug-Resistant Tuberculosis.耐多药结核病的治疗结果
N Engl J Med. 2016 Sep 15;375(11):1103-5. doi: 10.1056/NEJMc1603274.
2
[Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].[阿尔汉格尔斯克地区监狱中结核分枝杆菌多重耐药性的传播及其对结核病患者治疗效果的影响]
Probl Tuberk Bolezn Legk. 2005(5):19-21.
3
Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.七种抗结核分枝杆菌二线口服药物的野生型分布。
Int J Tuberc Lung Dis. 2011 Apr;15(4):502-9. doi: 10.5588/ijtld.10.0238.
4
Drug-resistant tuberculosis: reality and potential threat.耐药结核病：现状与潜在威胁
Int J Tuberc Lung Dis. 2010 Mar;14(3):255-8.
5
Treatment outcome monitoring of pulmonary tuberculosis cases notified in France in 2009.2009 年法国报告肺结核病例的治疗效果监测。
Euro Surveill. 2013 Mar 21;18(12):20434.
6
Treatment outcomes among patients with multidrug-resistant tuberculosis.耐多药结核病患者的治疗结果。
Lancet Infect Dis. 2010 Apr;10(4):215; author reply 215-6. doi: 10.1016/S1473-3099(10)70047-5.
7
[Mycobacterium tuberculosis with extensive resistance].具有广泛耐药性的结核分枝杆菌
Med Sci (Paris). 2007 Feb;23(2):205-9. doi: 10.1051/medsci/2007232205.
8
Drug-resistant tuberculosis: time for visionary political leadership.耐药结核病：是时候发挥富有远见的政治领导力了。
Lancet Infect Dis. 2013 Jun;13(6):529-39. doi: 10.1016/S1473-3099(13)70030-6. Epub 2013 Mar 24.
9
Management of multidrug resistant tuberculosis.耐多药结核病的管理。
Semin Respir Crit Care Med. 2013 Feb;34(1):44-59. doi: 10.1055/s-0032-1333546. Epub 2013 Mar 4.
10
[Difficulties in the treatment of pulmonary tuberculosis in children].[儿童肺结核治疗中的困难]
Rev Med Chir Soc Med Nat Iasi. 2007 Oct-Dec;111(4):852-5.

引用本文的文献

1
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.利奈唑胺、德拉马尼和重新用于耐药结核病治疗的药物延长治疗后痰培养阴转。
Nat Commun. 2024 May 9;15(1):3927. doi: 10.1038/s41467-024-48077-8.
2
Multidrug-resistant tuberculosis.耐多药结核病。
Nat Rev Dis Primers. 2024 Mar 24;10(1):22. doi: 10.1038/s41572-024-00504-2.
3
At Long Last: Short, All-Oral Regimens for Multidrug-Resistant Tuberculosis in the United States.终于：美国针对耐多药结核病的简短全口服治疗方案
Open Forum Infect Dis. 2023 Apr 3;10(4):ofad177. doi: 10.1093/ofid/ofad177. eCollection 2023 Apr.
4
FLASH-TB: an Application of Next-Generation CRISPR to Detect Drug Resistant Tuberculosis from Direct Sputum.FLASH-TB：一种利用下一代 CRISPR 技术从直接痰液中检测耐多药结核病的应用。
J Clin Microbiol. 2023 Apr 20;61(4):e0163422. doi: 10.1128/jcm.01634-22. Epub 2023 Apr 3.
5
A Scoring System Based on Laboratory Parameters and Clinical Features to Predict Unfavorable Treatment Outcomes in Multidrug- and Rifampicin-Resistant Tuberculosis Patients.一种基于实验室参数和临床特征的评分系统，用于预测耐多药和耐利福平结核病患者的不良治疗结局
Infect Drug Resist. 2023 Jan 10;16:225-237. doi: 10.2147/IDR.S397304. eCollection 2023.
6
Multidrug-resistant tuberculosis in Finland: treatment outcome and the role of whole-genome sequencing.芬兰的耐多药结核病：治疗结果与全基因组测序的作用
ERJ Open Res. 2022 Nov 28;8(4). doi: 10.1183/23120541.00214-2022. eCollection 2022 Oct.
7
Comparison of treatment outcome definitions in drug-resistant tuberculosis patients with high incidence of acquired second-line drug resistance.获得性二线耐药高发生率的耐药结核病患者治疗结局定义的比较
Afr J Thorac Crit Care Med. 2022 Jul 15;28(2). doi: 10.7196/AJTCCM.2022.v28i2.177. eCollection 2022.
8
Updated WHO definitions for tuberculosis outcomes: Simplified, unified and future-proofed.世界卫生组织结核病转归的更新定义：简化、统一且面向未来。
Afr J Thorac Crit Care Med. 2022 Jul 15;28(2). doi: 10.7196/AJTCCM.2022.v28i2.224. eCollection 2022.
9
Tuberculostearic Acid-Containing Phosphatidylinositols as Markers of Bacterial Burden in Tuberculosis.含结核酸的肌醇磷脂作为结核病细菌负荷的标志物。
ACS Infect Dis. 2022 Jul 8;8(7):1303-1315. doi: 10.1021/acsinfecdis.2c00075. Epub 2022 Jun 28.
10
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.结核病治疗监测和结局指标：新的关注点和新策略。
Clin Microbiol Rev. 2022 Sep 21;35(3):e0022721. doi: 10.1128/cmr.00227-21. Epub 2022 Mar 21.